These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 16023810)
1. Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate. Yamaguchi M; Yasueda S; Isowaki A; Yamamoto M; Kimura M; Inada K; Ohtori A Int J Pharm; 2005 Sep; 301(1-2):121-8. PubMed ID: 16023810 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic features of difluprednate ophthalmic emulsion in rabbits as determined by glucocorticoid receptor-binding bioassay. Tajika T; Waki M; Tsuzuki M; Kida T; Sakaki H J Ocul Pharmacol Ther; 2011 Feb; 27(1):29-34. PubMed ID: 21182429 [TBL] [Abstract][Full Text] [Related]
3. Ocular distribution of difluprednate ophthalmic emulsion 0.05% in rabbits. Tajika T; Isowaki A; Sakaki H J Ocul Pharmacol Ther; 2011 Feb; 27(1):43-9. PubMed ID: 21118027 [TBL] [Abstract][Full Text] [Related]
4. Metabolic profiles of difluprednate in rabbit ocular tissues after instillation of difluprednate ophthalmic emulsion. Tajika T; Takahashi H; Sakai Y; Fujii H; Isowaki A; Sakaki H Xenobiotica; 2010 Aug; 40(8):569-77. PubMed ID: 20509750 [TBL] [Abstract][Full Text] [Related]
5. Analysis of an anti-inflammatory steroidal drug, difluprednate, in aqueous humor by combination of semi-micro HPLC and column switching method. Yasueda S; Kimura M; Ohtori A; Kakehi K J Pharm Biomed Anal; 2003 Jan; 30(6):1735-42. PubMed ID: 12485714 [TBL] [Abstract][Full Text] [Related]
6. Understanding drug distribution and release in ophthalmic emulsions through quantitative evaluation of formulation-associated variables. Dong Y; Hengst L; Hunt R; Patel D; Vo A; Choi S; Ashraf M; Cruz CN; Xu X J Control Release; 2019 Nov; 313():96-105. PubMed ID: 31536731 [TBL] [Abstract][Full Text] [Related]
7. Application of Ultra-Centrifugation and Bench-Top Wang X; Patil SM; Keire DA; Xu X; Chen K AAPS PharmSciTech; 2018 May; 19(4):1647-1651. PubMed ID: 29500761 [TBL] [Abstract][Full Text] [Related]
8. Suspensions of antibiotics in self-emulsifying oils as a novel approach to formulate eye drops with substances which undergo hydrolysis in aqueous environment. Krzeminska K; Sznitowska M; Wroblewska M; Wolska E; Winnicka K Drug Deliv; 2024 Dec; 31(1):2372279. PubMed ID: 38992340 [TBL] [Abstract][Full Text] [Related]
10. Durezol (Difluprednate Ophthalmic Emulsion 0.05%) compared with Pred Forte 1% ophthalmic suspension in the treatment of endogenous anterior uveitis. Foster CS; Davanzo R; Flynn TE; McLeod K; Vogel R; Crockett RS J Ocul Pharmacol Ther; 2010 Oct; 26(5):475-83. PubMed ID: 20809807 [TBL] [Abstract][Full Text] [Related]
11. Oil components modulate physical characteristics and function of the natural oil emulsions as drug or gene delivery system. Chung H; Kim TW; Kwon M; Kwon IC; Jeong SY J Control Release; 2001 Apr; 71(3):339-50. PubMed ID: 11295226 [TBL] [Abstract][Full Text] [Related]
12. Novel NSAIDs ophthalmic formulation: flurbiprofen axetil emulsion with low irritancy and improved anti-inflammation effect. Shen J; Gan L; Zhu C; Zhang X; Dong Y; Jiang M; Zhu J; Gan Y Int J Pharm; 2011 Jun; 412(1-2):115-22. PubMed ID: 21440613 [TBL] [Abstract][Full Text] [Related]
13. Effect of composition on biological fate of oil particles after intravenous injection of O/W lipid emulsions. Sakaeda T; Hirano K J Drug Target; 1998; 6(4):273-84. PubMed ID: 9894695 [TBL] [Abstract][Full Text] [Related]
14. A Comparative Preclinical Evaluation of a Novel Difluprednate 0.04% BID Ophthalmic Solution and Marketed 0.05% QID Ophthalmic Emulsion. Khopade AJ; Halder A; Patel V; Shah H; Shah A; Burade V; Zalawadia R; Patel A; Awati C; Zope M J Ocul Pharmacol Ther; 2024; 40(1):57-66. PubMed ID: 37922455 [No Abstract] [Full Text] [Related]
15. Formulation parameters influencing the physicochemical characteristics of rosiglitazone-loaded cationic lipid emulsion. Davaa E; Park JS Arch Pharm Res; 2012 Jul; 35(7):1205-13. PubMed ID: 22864743 [TBL] [Abstract][Full Text] [Related]
16. Development of Clotrimazole Multiple W/O/W Emulsions as Vehicles for Drug Delivery: Effects of Additives on Emulsion Stability. Suñer J; Calpena AC; Clares B; Cañadas C; Halbaut L AAPS PharmSciTech; 2017 Feb; 18(2):539-550. PubMed ID: 27126008 [TBL] [Abstract][Full Text] [Related]
18. Formulation and in vitro evaluation of a cosmetic emulsion from almond oil. Akhtar N; Ahmad M; - G; Masood MI; Aleem M Pak J Pharm Sci; 2008 Oct; 21(4):430-7. PubMed ID: 18930867 [TBL] [Abstract][Full Text] [Related]
19. [Study on Chinese herbs' volatile oil micro-emulsions by means of pseudo-ternary phase diagram]. Yang MM; Zhang Y; Liu XY; Zhang TT; Liu M Zhong Yao Cai; 2011 Aug; 34(8):1288-92. PubMed ID: 22233047 [TBL] [Abstract][Full Text] [Related]
20. Effect of 0.05% Difluprednate Ophthalmic Emulsion on Proinflammatory Cytokine Levels After Retinal Laser Photocoagulation in Rabbits. Kakimoto H; Takamura Y; Arimura S; Miyake S; Matsumura T; Gozawa M; Iwasaki K; Morioka M; Yamada Y; Inatani M J Ocul Pharmacol Ther; 2018 Jun; 34(5):410-415. PubMed ID: 29812993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]